Explore our news and publications to discover groundbreaking research, innovative drug developments, and insightful analyses on aging and longevity. Follow our journey as we share updates and breakthroughs.
Experts across scientific and clinical fields, writing in Nature Oncogene, explore the emerging role of necrosis in aging—pointing to its potential to reshape how we understand and treat age-related conditions.
The Smart Grant will be used in a one-year project involving the company’s Anti-Necrotic™ technology, specifically around acute tubular necrosis (ATN), which is a leading cause of kidney dysfunction, degeneration and ageing.
Based at Babraham Research Campus, affiliated with the University of Cambridge, LinkGevity has been chosen for KQ Labs Programme delivered by the Francis Crick Institute. “Designed to propel world-class healthcare innovation, LinkGevity’s therapeutic data, innovative approach and scientific leadership secured its place in the cohort.”
Stay informed about the latest seminars, talks, and other public communications of our groundbreaking research and discoveries.
